{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:53:44Z","timestamp":1790798024268,"version":"4.1.0"},"reference-count":59,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T00:00:00Z","timestamp":1536537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2011-0030132"],"award-info":[{"award-number":["2011-0030132"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2016R1D1A3B04933830"],"award-info":[{"award-number":["2016R1D1A3B04933830"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chonnam National University Hwasun Hospital Institute for Biomedical Science","award":["HCRI17904-22"],"award-info":[{"award-number":["HCRI17904-22"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>CD46 is generally overexpressed in many human cancers, representing a prime target for CD46-binding adenoviruses (Ads). This could help to overcome low anti-tumoral activity by coxsackie-adenoviral receptor (CAR)-targeting cancer gene therapy viruses. However, because of scarce side-by-side information about CAR and CD46 expression levels in cancer cells, mixed observations of cancer therapeutic efficacy have been observed. This study evaluated Ad-mediated therapeutic efficacy using either CAR-targeting Ad5 or CD46-targeting Ad5\/35 fiber chimera in bladder cancer cell lines. Compared with normal urothelia, bladder cancer tissue generally overexpressed both CAR and CD46. While CAR expression was not correlated with disease progression, CD46 expression was inversely correlated with tumor grade, stage, and risk grade. In bladder cancer cell lines, expression levels of CD46 and CAR were highly correlated with Ad5\/35- and Ad5-mediated gene transduction and cytotoxicity, respectively. In a human EJ bladder cancer xenograft mouse model, with either overexpressed or suppressed CD46 expression levels, Ad5\/35-tk followed by ganciclovir (GCV) treatment significantly affected tumor growth, whereas Ad5-tk\/GCV had only minimal effects. Overall, our findings suggest that bladder cancer cells overexpress both CAR and CD46, and that adenoviral cancer gene therapy targeting CD46 represents a more suitable therapy option than a CAR-targeting therapy, especially in patients with low risk bladder cancers.<\/jats:p>","DOI":"10.3390\/ijms19092694","type":"journal-article","created":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T10:28:57Z","timestamp":1536575337000},"page":"2694","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Targeting CD46 Enhances Anti-Tumoral Activity of Adenovirus Type 5 for Bladder Cancer"],"prefix":"10.3390","volume":"19","author":[{"given":"Manh-Hung","family":"Do","sequence":"first","affiliation":[{"name":"Department of Anatomy, Chonnam National University Medical School, Gwangju 61469, Korea"},{"name":"Institute of Genome Research, Vietnam Academy of Science and Technology, Hanoi 122121, Viet Nam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuong Kim","family":"To","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Chonnam National University Medical School, Gwangju 61469, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Suk","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Chonnam National University Medical School, Gwangju 61469, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se-Young","family":"Kwon","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Chonnam National University Medical School, Gwangju 61469, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eu Chang","family":"Hwang","sequence":"additional","affiliation":[{"name":"Department of Urology, Chonnam National University Medical School, Gwangju 61469, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Chonnam National University Medical School, Gwangju 61469, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hee","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Hemato-Oncology, Chonnam National University Medical School, Gwangju 61469, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Jin","family":"Lee","sequence":"additional","affiliation":[{"name":"Genitourinary Cancer Branch, Research Institute of National Cancer Center, Goyang 10408, Gyeonggi-do, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Hemmi","sequence":"additional","affiliation":[{"name":"Institute of Molecular Life Sciences, University of Zurich, Zurich 8057, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaeyong","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Chonnam National University Medical School, Gwangju 61469, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,9,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1756287211431976","article-title":"Best practice in the treatment of nonmuscle invasive bladder cancer","volume":"4","author":"Anastasiadis","year":"2012","journal-title":"Ther. Adv. Urol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/gt.2011.180","article-title":"Antitumor effects of bladder cancer-specific adenovirus carrying e1a-androgen receptor in bladder cancer","volume":"19","author":"Zhai","year":"2012","journal-title":"Gene Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.juro.2007.09.003","article-title":"Guideline for the management of nonmuscle invasive bladder cancer (stages ta, t1, and tis): 2007 update","volume":"178","author":"Hall","year":"2007","journal-title":"J. Urol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/MOU.0b013e32830b86e3","article-title":"Gene therapy in bladder cancer","volume":"18","author":"Bochner","year":"2008","journal-title":"Curr. Opin. Urol."},{"key":"ref_6","unstructured":"John, W., and Sons Ltd. (2018, September 09). Vectors Used in Gene Therapy Clinical Trials. Available online: http:\/\/www.abedia.com\/wiley\/vectors.php."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2174\/1566523213666131125095046","article-title":"Adenovirus vectors for gene therapy, vaccination and cancer gene therapy","volume":"13","author":"Wold","year":"2013","journal-title":"Curr. Gene Ther."},{"key":"ref_8","first-page":"2535","article-title":"Alternate serotype adenovector provides long-term therapeutic gene expression in the eye","volume":"14","author":"Hamilton","year":"2008","journal-title":"Mol. Vis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"7909","DOI":"10.1128\/JVI.72.10.7909-7915.1998","article-title":"The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups a,c,d,e, and f","volume":"72","author":"Roelvink","year":"1998","journal-title":"J. Virol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1128\/JVI.78.9.4454-4462.2004","article-title":"The human membrane cofactor cd46 is a receptor for species b adenovirus serotype 3","volume":"78","author":"Sirena","year":"2004","journal-title":"J. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.juro.2006.10.034","article-title":"A histone deacetylase inhibitor enhances adenoviral infection of renal cancer cells","volume":"177","author":"Okegawa","year":"2007","journal-title":"J. Urol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.3390\/v2102196","article-title":"Serotype chimeric human adenoviruses for cancer gene therapy","volume":"2","author":"Ranki","year":"2010","journal-title":"Viruses"},{"key":"ref_13","first-page":"847","article-title":"Modulation of coxsackie-adenovirus receptor expression for increased adenoviral transgene expression","volume":"63","author":"Hemminki","year":"2003","journal-title":"Cancer Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tips.2012.04.005","article-title":"Adenovirus receptors: Implications for targeting of viral vectors","volume":"33","author":"Arnberg","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"9183","DOI":"10.1128\/JVI.77.17.9183-9191.2003","article-title":"Adenovirus type 11 uses cd46 as a cellular receptor","volume":"77","author":"Segerman","year":"2003","journal-title":"J. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/nm952","article-title":"Cd46 is a cellular receptor for group b adenoviruses","volume":"9","author":"Gaggar","year":"2003","journal-title":"Nat. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"6390","DOI":"10.1128\/JVI.00514-11","article-title":"Multimerization of adenovirus serotype 3 fiber knob domains is required for efficient binding of virus to desmoglein 2 and subsequent opening of epithelial junctions","volume":"85","author":"Wang","year":"2011","journal-title":"J. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nm.2270","article-title":"Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14","volume":"17","author":"Wang","year":"2011","journal-title":"Nat. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"38210","DOI":"10.18632\/oncotarget.9427","article-title":"Efficacy of cd46-targeting chimeric ad5\/35 adenoviral gene therapy for colorectal cancers","volume":"7","author":"Cho","year":"2016","journal-title":"Oncotarget"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev.iy.09.040191.002243","article-title":"Membrane cofactor protein (mcp or cd46): Newest member of the regulators of complement activation gene cluster","volume":"9","author":"Liszewski","year":"1991","journal-title":"Annu. Rev. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1128\/JVI.78.9.4385-4388.2004","article-title":"Four viruses, two bacteria, and one receptor: Membrane cofactor protein (cd46) as pathogens\u2019 magnet","volume":"78","author":"Cattaneo","year":"2004","journal-title":"J. Virol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1158\/0008-5472.CAN-14-2533","article-title":"Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer","volume":"75","author":"Galanis","year":"2015","journal-title":"Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1038\/sj.bjc.6690604","article-title":"Expression of membrane cofactor protein (mcp, cd46) in human liver diseases","volume":"80","author":"Kinugasa","year":"1999","journal-title":"Br. J. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00262-004-0590-0","article-title":"Do poor-prognosis breast tumours express membrane cofactor proteins (cd46)?","volume":"54","author":"Madjd","year":"2005","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1699-0463.1998.tb00233.x","article-title":"The complement regulatory proteins cd46 and cd59, but not cd55, are highly expressed by glandular epithelium of human breast and colorectal tumour tissues","volume":"106","author":"Thorsteinsson","year":"1998","journal-title":"APMIS"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1182\/blood.V98.5.1352","article-title":"Expression of complement inhibitors cd46, cd55, and cd59 on tumor cells does not predict clinical outcome after rituximab treatment in follicular non-hodgkin lymphoma","volume":"98","author":"Weng","year":"2001","journal-title":"Blood"},{"key":"ref_27","first-page":"831","article-title":"Increased infectivity of adenovirus type 5 bearing type 11 or type 35 fibers to human esophageal and oral carcinoma cells","volume":"14","author":"Yu","year":"2005","journal-title":"Oncol. Rep."},{"key":"ref_28","first-page":"159","article-title":"The role of membrane complement regulatory proteins in cancer immunotherapy","volume":"632","author":"Yan","year":"2008","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.1128\/JVI.77.15.8263-8271.2003","article-title":"Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: Efficient human cell infection and bypass of preexisting adenovirus immunity","volume":"77","author":"Vogels","year":"2003","journal-title":"J. Virol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/8647","article-title":"A system for the propagation of adenoviral vectors with genetically modified receptor specificities","volume":"17","author":"Douglas","year":"1999","journal-title":"Nat. Biotechnol."},{"key":"ref_31","first-page":"1262","article-title":"Substitution of the adenovirus serotype 5 knob with a serotype 3 knob enhances multiple steps in virus replication","volume":"63","author":"Kawakami","year":"2003","journal-title":"Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1525-0016(03)00243-0","article-title":"Characterization of in vitro and in vivo gene transfer properties of adenovirus serotype 35 vector","volume":"8","author":"Sakurai","year":"2003","journal-title":"Mol. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0042-6822(03)00161-2","article-title":"Development of adenovirus serotype 35 as a gene transfer vector","volume":"311","author":"Ganesh","year":"2003","journal-title":"Virology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s10495-015-1171-8","article-title":"Replication-competent adenoviruses with the type 35-derived fiber-knob region achieve reactive oxygen species-dependent cytotoxicity and produce greater toxicity than those with the type 5-derived region in pancreatic carcinoma","volume":"20","author":"Yamauchi","year":"2015","journal-title":"Apoptosis"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/gt.2013.44","article-title":"Pseudotyping the adenovirus serotype 5 capsid with both the fibre and penton of serotype 35 enhances vascular smooth muscle cell transduction","volume":"20","author":"Parker","year":"2013","journal-title":"Gene Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/cgt.2011.74","article-title":"Efficient antitumor effects of carrier cells loaded with a fiber-substituted conditionally replicating adenovirus on car-negative tumor cells","volume":"19","author":"Iguchi","year":"2012","journal-title":"Cancer Gene Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"404581","DOI":"10.1155\/2012\/404581","article-title":"Oncolytic viruses in the treatment of bladder cancer","volume":"2012","author":"Potts","year":"2012","journal-title":"Adv. Urol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00281-005-0002-3","article-title":"Emerging roles and new functions of cd46","volume":"27","author":"Liszewski","year":"2005","journal-title":"Springer Semin. Immunopathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.gene.2017.05.004","article-title":"Alternative polyadenylation expands the mrna isoform repertoire of human cd46","volume":"625","author":"Ly","year":"2017","journal-title":"Gene"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","article-title":"Isolation of a common receptor for coxsackie b viruses and adenoviruses 2 and 5","volume":"275","author":"Bergelson","year":"1997","journal-title":"Science"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1073\/pnas.94.7.3352","article-title":"Hcar and mcar: The human and mouse cellular receptors for subgroup c adenoviruses and group b coxsackieviruses","volume":"94","author":"Tomko","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1089\/hum.1998.9.16-2363","article-title":"The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures","volume":"9","author":"Hemmi","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/sj.cgt.7700284","article-title":"Coxsackievirus-adenovirus receptor expression in ovarian cancer cell lines is associated with increased adenovirus transduction efficiency and transgene expression","volume":"8","author":"You","year":"2001","journal-title":"Cancer Gene Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/S0959-8049(02)00131-4","article-title":"The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells","volume":"38","author":"Kim","year":"2002","journal-title":"Eur. J. Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1006\/gyno.2002.6607","article-title":"Enhancement of the adenoviral sensitivity of human ovarian cancer cells by transient expression of coxsackievirus and adenovirus receptor (car)","volume":"85","author":"Kim","year":"2002","journal-title":"Gynecol. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11010-011-0778-5","article-title":"Increased antitumor capability of fiber-modified adenoviral vector armed with trail against bladder cancers","volume":"353","author":"Zhao","year":"2011","journal-title":"Mol. Cell. Biochem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"920.e7","DOI":"10.1016\/j.urology.2012.12.023","article-title":"Fiber-substituted conditionally replicating adenovirus ad5f35 induces oncolysis of human bladder cancer cells in in vitro analysis","volume":"81","author":"Gotoh","year":"2013","journal-title":"Urology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/PAI.0b013e31821a0be9","article-title":"Cd46 expression is an unfavorable prognostic factor in breast cancer cases","volume":"19","author":"Maciejczyk","year":"2011","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"910","DOI":"10.5858\/arpa.2013-0064-OA","article-title":"Systematic immunohistochemical analysis of the expression of cd46, cd55, and cd59 in colon cancer","volume":"138","author":"Shang","year":"2014","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/neuonc\/noq057","article-title":"Treatment of medulloblastoma with a modified measles virus","volume":"12","author":"Studebaker","year":"2010","journal-title":"Neuro Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1517\/14712598.8.6.759","article-title":"Complement and cellular cytotoxicity in antibody therapy of cancer","volume":"8","author":"Wang","year":"2008","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.ejca.2014.05.005","article-title":"The complement receptors cd46, cd55 and cd59 are regulated by the tumour microenvironment of head and neck cancer to facilitate escape of complement attack","volume":"50","author":"Kesselring","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrg2141","article-title":"Engineering targeted viral vectors for gene therapy","volume":"8","author":"Waehler","year":"2007","journal-title":"Nat. Rev. Genet."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/cas.12267","article-title":"Enhanced antitumor efficacy of fiber-modified, midkine promoter-regulated oncolytic adenovirus in human malignant mesothelioma","volume":"104","author":"Yamano","year":"2013","journal-title":"Cancer Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1158\/0008-5472.CAN-09-0645","article-title":"Epithelial phenotype confers resistance of ovarian cancer cells to oncolytic adenoviruses","volume":"69","author":"Strauss","year":"2009","journal-title":"Cancer Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1089\/hum.2005.16.664","article-title":"Evaluation of biodistribution and safety of adenovirus vectors containing group b fibers after intravenous injection into baboons","volume":"16","author":"Ni","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1128\/JVI.06181-11","article-title":"Avidity binding of human adenovirus serotypes 3 and 7 to the membrane cofactor cd46 triggers infection","volume":"86","author":"Trinh","year":"2012","journal-title":"J. Virol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1158\/0008-5472.CAN-04-3666","article-title":"Gene therapy for prostate cancer by controlling adenovirus e1a and e4 gene expression with pses enhancer","volume":"65","author":"Li","year":"2005","journal-title":"Cancer Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1006\/mthe.2002.0682","article-title":"Novel prostate-specific promoter derived from psa and psma enhancers","volume":"6","author":"Lee","year":"2002","journal-title":"Mol. Ther."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/9\/2694\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:19:44Z","timestamp":1760195984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/9\/2694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,10]]},"references-count":59,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9]]}},"alternative-id":["ijms19092694"],"URL":"https:\/\/doi.org\/10.3390\/ijms19092694","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,10]]}}}